Happy Wednesday! In this week’s Big I Buzz: DIY home inspections are on the rise, and insurers face mounting pressure to support access to high-demand GLP-1 drugs.

DIY Home Inspections Are Taking Over, Firms Say

The future of home inspections may be in the homeowner's hands. Leaders from two firms developing DIY inspection systems—now used nationwide for pre-policy property surveys—say the trend is rapidly gaining momentum.

At the Insurance Innovators USA conference in Nashville, the head of EXL Survey and Business Control emphasized that DIY inspections are no longer a question of "if" but "how to implement."

While some homeowners may initially hesitate to submit photos of a water stain or a precariously placed tree limb, most are willing to participate—especially when they learn it can reduce costs and eliminate the disruption of a traditional in-person inspection. Read more here.

Insurance Companies Scrambling to Support Need for GLP-1 Drugs

Insurers are racing to address the skyrocketing demand for GLP-1 drugs like Ozempic, Wegovy, and Mounjaro. Originally developed for diabetes, these medications are now widely used for weight loss—creating a complex challenge for the insurance industry.

The dilemma? Balancing consumer access with soaring drug costs. While the current strategy is to manage short-term expenses while waiting for long-term data and potential competition from generics or biosimilars, some experts warn that delaying action could prove costly as demand continues to climb. Read more here.

For more news, check out the Action News section of our weekly e-newsletter, Big I Buzz. If you aren’t subscribed, click here to add your email to our emailing list.